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Factors Associated with Maternal Mortality in Nyakabande
Subcounty, Kisoro District in Uganda
J.K. Kabami
Uganda Research Institute, Mbarara, Uganda
Pregnancy and childbirth should be viewed as a happy
and joyous event but the majority of women who become
pregnant experience pain, fear, suffering and even death.
About one million women are estimated to get pregnant
every year. Out of these, at least 1600 women die every day
from pregnancy-related complications and childbirth. Of all
maternal deaths that occur globally, 99% are in developing
countries compared to 1% that occurs in developed countries
(WHO, 1996; UNICEF 1996; CARE, 1998).
Uganda is a developing country with a very high mater-
nal mortality rate. The revised UNICEF/WHO 1990 global,
regional and individual country estimations maternal mor-
tality rates put the Ugandan rate at 1200 maternal deaths
per 100,000 live births.
The study was conducted in Nyakabande Sub County in
Kisoro district in South Western Uganda to establish the main
factors associated with maternal mortality. The study also
sought to identify the socio-economic, cultural, physical and
health care factors associated with maternal mortality.
Data was obtained from the ofﬁce of the District Direc-
tor of Health Services (DDHS) from 1998—2002, health units,
health workers and pregnant women by means of pre-tested
questionnaires and focus group discussion guides.
The study was descriptive and cross-sectional in nature.
The population under study included women of reproductive
age, pregnant women, nurses and midwives.
The main causes of maternal deaths (N = 29) were malaria
in pregnancy (34.9%), post-partum haemorrhage (17.4%)
purpueral sepsis (17.4%), cerebral malaria (4.3%). Amniotic
embolism (4.3%) pulmonary embolism (4.3%) pre-eclampsia
(4.3%) HIV in pregnancy (4.3%).
There were frequent deaths among women with the third
to sixth pregnancy: 3—4 pregnancies (30.4%), 5—6 pregnan-
cies (26.1%). Most of the maternal deaths occurred in the
age group of 20—29 years (52.2%).
The ﬁndings indicate a high maternal mortality in Nyak-
abande Sub-county that is related to several personal,
socio-economic and health care factors.
doi:10.1016/j.ijid.2008.05.1275
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Background: In Australia the zoster vaccine has recently
been approved for people aged 50 years and older. The aims
of this study were to determine the health care burden and
expenses associated with herpes zoster in this population,
important background data to enable analyses of the impact
and cost-effectiveness of the introduction of the zoster vac-
cine.
Methods: Incidence of zoster and post herpetic neural-
gia (PHN) and associated health care resource utilisation
were investigated using data from Bettering the Evaluation
and Care of Health (BEACH) (April 2000—September 2006),
pharmaceutical prescribing data, and hospital morbidity and
emergency department databases (1998—2005)
Results: The BEACH database recorded 379 encounters
for new zoster and 57 for new PHN in subjects aged 50+,
extrapolating to ∼58,350 zoster and 8,800 PHN cases/year
throughout Australia. The estimated zoster incidence rate
was 9.7/1,000 persons (95% CI: 8.7—10.7) increasing from
6.5/1,000 at 50—59 to 15.6/1,000 at age 80+. PHN incidence
was 1.45 (1.1—1.8)/1,000, with risk in zoster cases increas-
ing from ∼11% at 50—59 to ∼20% at 80+ years. Between 1998
- 2005 there were 4,058 zoster hospitalizations/year, an esti-
mated rate of 0.67/1,000, with herpes zoster recorded as
principal diagnosis in ∼41%. There were estimated aver-
ages of ∼340 admitted and ∼1900 non-admitted emergency
department visits/year (∼0.38/1,000). Zoster or PHN were
managed at 901 encounters, extrapolating to 139,000 annual
general practitioner consultations (∼2.4 visits/case) with
referrals to specialists recorded in 1.8% of cases. Antivi-
rals were prescribed for 73.5% of new zoster cases. Other
medications included opioids, other analgesics, antidepres-
sants and antiepileptics. Total costs of zoster and PHN to the
health care system were estimated as ∼33.3million/year
Conclusions: The substantial burden of zoster and PHN
described in this study supports the case for inclusion of
the zoster vaccine in the Australian National Immunisation
Program.
doi:10.1016/j.ijid.2008.05.1276
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Background: The volume and widespread nature of mod-
ern international travel is a factor in the emergence of
infectious diseases. Through the surveying of departing pas-
sengers we aimed to describe traveller behaviour, providing
relevant data to support prevention and control activities in
travel-related infectious disease importation and spread.
Methods: Between August-September 2007, we con-
ducted a survey of travellers departing from Sydney
International Airport, including Australian residents and vis-
itors to Australia. Passengers were randomly selected for
